
Atara Biotherapeutics, Inc.: shareholders and insiders
Price
$6.50
November 17, 2026Market cap $100M
What Ploutos Investor adds for Atara Biotherapeutics
Part of Ploutos Investor, €9.99 a month
- The full history: 4 fiscal years, from 2022
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 22% since Nov 10, 2026, when the 10-Q these figures come from was filed ($8.10 then, $6.29 on Nov 17, 2026). The figures date from before that move.10-Q
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Sep 4, 2026, from their own Form 4 filings.
Bought on the market
$5.7M
2 people
Sold on the market
$3.8M
4 people
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $5.7M by 2 people·sold $3.8M by 4 people
- 2025: no buys, no sales
- 2026: bought $5.7M by 2 people, sold $3.8M by 4 people
- Sep 4, 2026Brian N CherryDirectorKind
- Aug 17, 2026AnhCo NguyenPresident and CEOKind
- Jul 22, 2026Redmile Group, LLCDirectorKind
- Jul 22, 2026Redmile Group, LLCDirectorKind
- Jun 11, 2026Brian N CherryDirectorKind
- Jun 9, 2026William K HeidenDirectorKind
- Jun 9, 2026Matthew K FustDirectorKind
- Jun 9, 2026Gregory Austin CiongoliDirectorKind
- May 18, 2026Yanina Grant-HuertaChief Accounting OfficerKind
- May 18, 2026AnhCo NguyenPresident and CEOKind
- May 7, 2026EcoR1 Capital, LLCKind
- May 7, 2026Panacea Innovation LtdKind
- Mar 2, 2026AnhCo NguyenPresident and CEOKind
- Mar 2, 2026AnhCo NguyenPresident and CEOKind
- Mar 2, 2026AnhCo NguyenPresident and CEOKind
- Mar 2, 2026AnhCo NguyenPresident and CEOKind
- Mar 2, 2026Yanina Grant-HuertaChief Accounting OfficerKind
- Mar 2, 2026Yanina Grant-HuertaChief Accounting OfficerKind
- Mar 2, 2026Yanina Grant-HuertaChief Accounting OfficerKind
- Mar 2, 2026Yanina Grant-HuertaChief Accounting OfficerKind
- Jan 12, 2026James HuangKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Brian N CherryDirector | 104.2K | $9.60 | $1,000.0K | Form 4 | |
| Aug 17, 2026 | AnhCo NguyenPresident and CEO | 5,062 | $8.08 | $40.9K | Form 4 | |
| Jul 22, 2026 | Redmile Group, LLCDirector | 195.2K | – | – | Form 4 | |
| Jul 22, 2026 | Redmile Group, LLCDirector | 60 | – | – | Form 4 | |
| Jun 11, 2026 | Brian N CherryDirector | 24.0K | – | – | Form 4 | |
| Jun 9, 2026 | William K HeidenDirector | 12.0K | – | – | Form 4 | |
| Jun 9, 2026 | Matthew K FustDirector | 12.0K | – | – | Form 4 | |
| Jun 9, 2026 | Gregory Austin CiongoliDirector | 12.0K | – | – | Form 4 | |
| May 18, 2026 | Yanina Grant-HuertaChief Accounting Officer | 2,414 | $9.13 | $22.0K | Form 4 | |
| May 18, 2026 | AnhCo NguyenPresident and CEO | 5,241 | $9.13 | $47.9K | Form 4 | |
| May 7, 2026 | EcoR1 Capital, LLC | 507.4K | $9.35 | $4.7M | Form 4 | |
| May 7, 2026 | Panacea Innovation Ltd | 313.4K | $10.10 | $3.2M | Form 4 | |
| Mar 2, 2026 | AnhCo NguyenPresident and CEO | 1,442 | $5.09 | $7.3K | Form 4 | |
| Mar 2, 2026 | AnhCo NguyenPresident and CEO | 198 | $5.08 | $1.0K | Form 4 | |
| Mar 2, 2026 | AnhCo NguyenPresident and CEO | 1,298 | $5.09 | $6.6K | Form 4 | |
| Mar 2, 2026 | AnhCo NguyenPresident and CEO | 58 | $5.08 | $295 | Form 4 | |
| Mar 2, 2026 | Yanina Grant-HuertaChief Accounting Officer | 100 | $5.08 | $508 | Form 4 | |
| Mar 2, 2026 | Yanina Grant-HuertaChief Accounting Officer | 24 | $5.08 | $122 | Form 4 | |
| Mar 2, 2026 | Yanina Grant-HuertaChief Accounting Officer | 1,603 | $5.08 | $8.1K | Form 4 | |
| Mar 2, 2026 | Yanina Grant-HuertaChief Accounting Officer | 377 | $5.08 | $1.9K | Form 4 | |
| Jan 12, 2026 | James Huang | 80.6K | $6.07 | $489.0K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 11, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by ATRA's officers and directors from 2014 up to November 17, 2025, 12 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 7 more, back to 2014
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Adiumentum Capital Fund I LPwith 2 more personsShare of class20.0%
- EcoR1 Capital, LLCwith 2 more personsShare of class17.4%
- Panacea Innovation Limitedwith 5 more personsShare of class16.1%
- Redmile Group, LLCwith 3 more personsShare of class9.90%
- Adage Capital Management, L.P.with 2 more personsShare of class8.56%
- Point72 Asset Management, L.P.with 2 more personsShare of class7.60%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Adiumentum Capital Fund I LPwith 2 more persons | 20.0% | 1.37M | May 16, 2025 | 13D/A | |
| EcoR1 Capital, LLCwith 2 more persons | 17.4% | 1.55M | May 7, 20262 filings since Nov 14, 2025 | 13G/A | |
| Panacea Innovation Limitedwith 5 more persons | 16.1% | 1.32M | May 11, 20265 filings since Feb 6, 2025 | 13D/A | |
| Redmile Group, LLCwith 3 more persons | 9.90% | 951.0K | Jul 24, 20265 filings since May 15, 2025 | 13D/A | |
| Adage Capital Management, L.P.with 2 more persons | 8.56% | 700.0K | May 13, 2026 | 13G | |
| Point72 Asset Management, L.P.with 2 more persons | 7.60% | 687.7K | Aug 14, 20262 filings since May 8, 2026 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Adiumentum Capital Fund I LP20.0%From the filing of May 16, 2025
Item 4 of the Initial 13D is hereby amended and supplemented to add the following information: On May 14, 2025, Adiumentum agreed to purchase from the Issuer in connection with a registered offering (the "Registered Offering") an aggregate of (i) 75,572 shares (the "Shares") of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"), and (ii) pre-funded warrants (each, a "Pre-Funded Warrant", and together, the "Pre-Funded Warrants") to purchase up to 227,000 shares of Common Stock, at a purchase price of $6.61 per share of Common Stock and $6.6099 per share of Common Stock issuable upon exercise of the Pre-Funded Warrants. The exercise price of each Pre-Funded Warrant…
From the filing of May 16, 2025Panacea Innovation Limited16.1%From the filing of May 21, 2025
On May 16, 2025, James Huang was appointed to the Board of Directors (the "Board") of the Issuer in connection with the completion of an underwritten, registered offering of Common Stock and warrants to purchase common stock. General The Reporting Persons acquired the securities described in this Schedule 13D for investment purposes and intend to review their investments in the Issuer on a continuing basis. Any actions the Reporting Persons might undertake may be made at any time and from time to time without prior notice and will be dependent upon the Reporting Persons' review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer's business, financial…
From the filing of May 21, 2025Redmile Group, LLC9.9%From the filing of May 23, 2025
The Reporting Persons acquired the securities covered by this Schedule 13D, including the New Warrants, for investment purposes, in the ordinary course of business. The Reporting Persons will routinely monitor a wide variety of investment considerations, including, without limitation, current and anticipated future trading prices for the Common Stock, the Issuer's operations, assets, prospects, business development, markets and capitalization, the Issuer's management and personnel, Issuer-related competitive and strategic matters, general economic, financial market and industry conditions, as well as other investment considerations. The Reporting Persons expect to discuss their investment…
From the filing of May 23, 2025
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter+254%
- Citadel Advisors (Griffin)In the quarter
- Millennium Mgmt (Englander)In the quarter-73%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | 687.7K | +254% | $7.9M | 0.01% |
| Citadel Advisors (Griffin) | 10.2K | $100.0K | 0.00% | |
| Millennium Mgmt (Englander) | 12.7K | -73% | $100.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 2.29% of its shares outstanding were held short, +8.8% since the report before.
- Shares held short
- 350.3K
- 2.29%
- Since the report before321.8K on Sep 30, 2026
- +8.8%
- 8.7
- 40.3K
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 12.49M
- Nov 15, 2023: Shares held short 8.16M
- Nov 30, 2023: Shares held short 11.11M
- Dec 15, 2023: Shares held short 10.13M
- Dec 29, 2023: Shares held short 9.19M
- Jan 12, 2024: Shares held short 7.33M
- Jan 31, 2024: Shares held short 7.53M
- Feb 15, 2024: Shares held short 10.87M
- Feb 29, 2024: Shares held short 10.14M
- Mar 15, 2024: Shares held short 11.03M
- Mar 28, 2024: Shares held short 11.23M
- Apr 15, 2024: Shares held short 11.45M
- Apr 30, 2024: Shares held short 11.88M
- May 15, 2024: Shares held short 11.62M
- May 31, 2024: Shares held short 11.27M
- Jun 14, 2024: Shares held short 10.78M
- Jun 28, 2024: Shares held short 575.3K
- Jul 15, 2024: Shares held short 540.0K
- Jul 31, 2024: Shares held short 360.5K
- Aug 15, 2024: Shares held short 378.5K
- Aug 30, 2024: Shares held short 410.5K
- Sep 13, 2024: Shares held short 463.0K
- Sep 30, 2024: Shares held short 526.4K
- Oct 15, 2024: Shares held short 639.2K
- Oct 31, 2024: Shares held short 636.3K
- Nov 15, 2024: Shares held short 519.5K
- Nov 29, 2024: Shares held short 544.0K
- Dec 13, 2024: Shares held short 551.5K
- Dec 31, 2024: Shares held short 533.6K
- Jan 15, 2025: Shares held short 547.8K
- Jan 31, 2025: Shares held short 706.5K
- Feb 14, 2025: Shares held short 674.6K
- Feb 28, 2025: Shares held short 715.1K
- Mar 14, 2025: Shares held short 723.3K
- Mar 31, 2025: Shares held short 666.8K
- Apr 15, 2025: Shares held short 662.2K
- Apr 30, 2025: Shares held short 522.1K
- May 15, 2025: Shares held short 412.9K
- May 30, 2025: Shares held short 367.4K
- Jun 13, 2025: Shares held short 285.8K
- Jun 30, 2025: Shares held short 266.6K
- Jul 15, 2025: Shares held short 268.0K
- Jul 31, 2025: Shares held short 210.6K
- Aug 15, 2025: Shares held short 196.2K
- Aug 29, 2025: Shares held short 173.8K
- Sep 15, 2025: Shares held short 161.5K
- Sep 30, 2025: Shares held short 149.6K
- Oct 15, 2025: Shares held short 128.8K
- Oct 31, 2025: Shares held short 168.5K
- Nov 14, 2025: Shares held short 176.8K
- Nov 28, 2025: Shares held short 164.7K
- Dec 15, 2025: Shares held short 166.9K
- Dec 31, 2025: Shares held short 169.2K
- Jan 15, 2026: Shares held short 1.02M
- Jan 30, 2026: Shares held short 282.5K
- Feb 13, 2026: Shares held short 209.3K
- Feb 27, 2026: Shares held short 330.5K
- Mar 13, 2026: Shares held short 313.3K
- Mar 31, 2026: Shares held short 327.1K
- Apr 15, 2026: Shares held short 318.0K
- Apr 30, 2026: Shares held short 306.1K
- May 15, 2026: Shares held short 546.5K
- May 29, 2026: Shares held short 484.4K
- Jun 15, 2026: Shares held short 492.4K
- Jun 30, 2026: Shares held short 361.5K
- Jul 15, 2026: Shares held short 577.6K
- Jul 31, 2026: Shares held short 536.9K
- Aug 14, 2026: Shares held short 477.3K
- Aug 31, 2026: Shares held short 427.4K
- Sep 15, 2026: Shares held short 404.3K
- Sep 30, 2026: Shares held short 321.8K
- Oct 15, 2026: Shares held short 350.3K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading50.1% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 50.1% of the shares in the reported trades were short sales, against 43.9% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 50.1%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 43.9%
- Change
- +6.2 pts
- Short sales a dayon average, of 8,741 shares
- 4,380
- More than atof 3,666 US-listed companies, same days
- 49%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 34%
- Oct 12, 2026: Short sales 16.8%
- Oct 13, 2026: Short sales 90.9%
- Oct 14, 2026: Short sales 21.8%
- Oct 15, 2026: Short sales 52.7%
- Oct 16, 2026: Short sales 44.8%
- Oct 19, 2026: Short sales 49.5%
- Oct 20, 2026: Short sales 30%
- Oct 21, 2026: Short sales 37.7%
- Oct 22, 2026: Short sales 37.1%
- Oct 23, 2026: Short sales 24.2%
- Oct 26, 2026: Short sales 51%
- Oct 27, 2026: Short sales 82%
- Oct 28, 2026: Short sales 61.4%
- Oct 29, 2026: Short sales 36.1%
- Oct 30, 2026: Short sales 37.1%
- Nov 2, 2026: Short sales 41%
- Nov 3, 2026: Short sales 71.4%
- Nov 4, 2026: Short sales 55.9%
- Nov 5, 2026: Short sales 42.5%
- Nov 6, 2026: Short sales 19.5%
- Nov 9, 2026: Short sales 23.5%
- Nov 10, 2026: Short sales 73%
- Nov 11, 2026: Short sales 51.7%
- Nov 12, 2026: Short sales 37%
- Nov 13, 2026: Short sales 46.2%
- Nov 16, 2026: Short sales 36%
- Nov 17, 2026: Short sales 77.7%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- EcoR1 Capital, LLCTenPercentOwnerDirectly–
- James HuangDirector,TenPercentOwnerDirectly–
- Gregory Austin CiongoliDirectorDirectly1.22M
- Panacea Innovation LtdTenPercentOwnerDirectly–
- Redmile Group, LLCDirectorDirectly636.9K
- Brian N CherryDirectorDirectly166.5K
- AnhCo NguyenPresident and CEODirectly132.8K
- Pascal TouchonPresident and CEODirectly70.4K
- Eric J HyllengrenEVP, CFO and COODirectly56.2K
- Yanina Grant-HuertaChief Accounting OfficerDirectly49.6K
- William K HeidenDirectorDirectly34.2K
- Matthew K FustDirectorDirectly30.2K
- Amar MuruganEVP, Chief Legal OfficerDirectly26.9K
- Jill HenrichEVP, Chief Regulatory OfficerDirectly18.7K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| EcoR1 Capital, LLCTenPercentOwner | – | 1.55M | May 7, 2026 | Form 4 |
| James HuangDirector,TenPercentOwner | – | 1.32M | Jan 12, 2026 | Form 4 |
| Gregory Austin CiongoliDirector | 1.22M | – | Jun 9, 2026 | Form 4 |
| Panacea Innovation LtdTenPercentOwner | – | 1.01M | May 7, 2026 | Form 4 |
| Redmile Group, LLCDirector | 636.9K | – | Jul 22, 2026 | Form 4 |
| Brian N CherryDirector | 166.5K | – | Sep 4, 2026 | Form 4 |
| AnhCo NguyenPresident and CEO | 132.8K | – | Aug 17, 2026 | Form 4 |
| Pascal TouchonPresident and CEO | 70.4K | – | Aug 16, 2024 | Form 4 |
| Eric J HyllengrenEVP, CFO and COO | 56.2K | – | Mar 3, 2025 | Form 4 |
| Yanina Grant-HuertaChief Accounting Officer | 49.6K | – | May 18, 2026 | Form 4 |
| William K HeidenDirector | 34.2K | – | Jun 9, 2026 | Form 4 |
| Matthew K FustDirector | 30.2K | – | Jun 9, 2026 | Form 4 |
| Amar MuruganEVP, Chief Legal Officer | 26.9K | – | Aug 16, 2024 | Form 4 |
| Jill HenrichEVP, Chief Regulatory Officer | 18.7K | – | Mar 3, 2025 | Form 4 |
A lower bound: it counts only the 14 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
| ETF | Weight in the fund | Holdings as of |
|---|---|---|
| IWCiShares Micro-Cap ETF | 0.01% | Jun 30, 2026 |
| VXFVanguard Extended Market Index Fund | 0.00% | Jun 30, 2026 |
| VTIVanguard Total Stock Market Index Fund | 0.00% | Jun 30, 2026 |
3 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 37
- Q4 2025: Managers 41
- Q1 2026: Managers 33
- Q2 2026: Managers 36
Institutional investors by quarter
The fund managers holding ATRA, quarter by quarter, from Q4 2014 to Q2 2025, 43 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 36 managers held 4.47M shares, worth $51M. During the quarter 4 opened a position, 1 closed one, 10 added and 8 trimmed.
The largest holders, Q2 2026
- EcoR1 CapitalIn the quarter×15.6
- Adage Capital Partners GpIn the quarter+21%
- Point72 (Cohen)In the quarter+254%
- Redmile GroupIn the quarter
- Vanguard Capital ManagementIn the quarter+13%
- Mackenzie FinancialIn the quarter-26%
- BlackRockIn the quarter+6.9%
- Geode Capital ManagementIn the quarter+14%
- Staley Capital AdvisersIn the quarter
- Vanguard Fiduciary TrustIn the quarter+28%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| EcoR1 Capital | 1.55M | ×15.6 | $18M |
| Adage Capital Partners Gp | 850.0K | +21% | $9.8M |
| Point72 (Cohen) | 687.7K | +254% | $7.9M |
| Redmile Group | 441.7K | $5.1M | |
| Vanguard Capital Management | 247.0K | +13% | $2.8M |
| Mackenzie Financial | 233.2K | -26% | $2.7M |
| BlackRock | 84.5K | +6.9% | $969.5K |
| Geode Capital Management | 75.1K | +14% | $862.9K |
| Staley Capital Advisers | 50.0K | $574.0K | |
| Vanguard Fiduciary Trust | 43.0K | +28% | $494.1K |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Atara Biotherapeutics's filings show?
Who buys and sells is one part of Atara Biotherapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have ATRA's insiders bought or sold?
From Jun 11, 2026 to Sep 4, 2026 Atara Biotherapeutics's insiders bought $1,000.0K and sold $40.9K of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold ATRA?
3 of the managers we track held the shares on Jun 30, 2026. The largest position was Point72 (Cohen)'s, worth $7.9M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.